Showing results (131-140 of 219) with videos related to

Sort By:
Pageof 22
Cancer Science|July 18, 2022
Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse modelKako Hanada, Kunpei Fukasawa, Hiroki Hinata, et al.
Biological Chemistry|December 4, 2004
Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteasesHamdy M Abdel-Rahman, Tooru Kimura, Koushi Hidaka, et al.
Biochemical and Biophysical Research Communications|August 12, 2009
YKL-40 secreted from adipose tissue inhibits degradation of type I collagenTakeo Iwata, Masamichi Kuwajima, Akiko Sukeno, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|March 23, 2017
HIV-1 susceptibility of transgenic rat-derived primary macrophage/T cells and a T cell line that express human receptors, CyclinT1 and CRM1 genesHisatoshi Shida, Hiroyuki Okada, Hajime Suzuki, et al.
Arthritis and Rheumatism|October 1, 2004
Effective treatment of a mouse model of Sjögren's syndrome with eyedrop administration of anti-CD4 monoclonal antibodyYuki Hayashi, Naozumi Ishimaru, Rieko Arakaki, et al.
Anti-Cancer Drugs|December 1, 2005
NPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agentBenjamin Nicholson, G Kenneth Lloyd, Brian R Miller, et al.
Revista Do Colegio Brasileiro De Cirurgioes|November 24, 2012
[Bacteriological study of bronchoalveolar lavage in the antibiotic management of suspected ventilator-associated pneumonia of patients in surgical intensive care units]Felipe Francisco Tuon, Lucas Wagner Gortz, Sergio Ricardo Penteado-Filho, et al.
RSC Medicinal Chemistry|February 27, 2023
Inactivation of myostatin by photooxygenation using functionalized d-peptidesHideyuki Okamoto, Shuko Amber Murano, Kaoru Ikekawa, et al.
Chemmedchem|February 17, 2021
Development of a High-Affinity Antibody-Binding Peptide for Site-Specific ModificationKyohei Muguruma, Rento Osawa, Akane Fukuda, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2007
Truncation and non-natural amino acid substitution studies on HTLV-I protease hexapeptidic inhibitorsJeffrey-Tri Nguyen, Meihui Zhang, Henri-Obadja Kumada, et al.
Pageof 22